The ecosystem in practice
The pipeline runs from research group to spin-out with the institute’s blessing and often its equity; shared facilities keep capital costs survivable; and the talent question answers itself — the graduates are already on campus, and international hires join on the kennismigrant route: the hiring page. Around the science sits a small, real supplier scene: control electronics, cryogenics, photonics — the ecosystem’s quiet second act.
Funding the decade
Quantum runs on patient stacks: the WBSO on the research payroll from day one (the credit), national and European deep-tech programmes layering grants over equity, and specialist funds that price decade horizons: the financing map. Revenue often arrives early through enabling products and research contracts — taxed at the friendly bracket while the moonshot compounds.
Structure for long-horizon IP
The chart is built for optionality: IP holding above, operating BV beneath, spin-off-ready per product line — so a licensing deal, a partnership or an acquisition of one line moves cleanly while the rest continues: the skeleton, the licensing chapter and, for the profitable years, the 9% box.